DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Levy GG, Asikanius E, Kuebler P, Benchikh El Fegoun S, Esbjerg S, Seremetis S.
Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: experience from the HAVEN clinical program.
J ThrombHaemost 2019;
17 (09) 1470-1477
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.